Hypertension, Vol 12, 498-505, Copyright © 1988 by American Heart Association
A Montanari, D Vallisa, G Ragni, A Guerra, R Colla, A Novarini and P Coruzzi
In nine young normotensive subjects with no family history of hypertension
and nine age-matched normotensive subjects with one parent with essential
hypertension, effective renal plasma flow (p- aminohippuric acid
clearance), glomerular filtration rate (inulin clearance), and excretion of
sodium and exogenously administered lithium were measured for 90 minutes
before and after administration of a single 20-mg oral dose of the calcium
entry blocker nifedipine. Segmental tubular handling of fluid and sodium
was estimated using lithium clearance as a marker of proximal tubular
reabsorption. Nifedipine did not cause any change in subjects with no
family history of hypertension, but in those with one hypertensive parent
there was a marked increase in effective renal plasma flow (from 644 +/- 39
to 847 +/- 42 [SEM] ml/min x 1.73 m2; p less than 0.001) and a decrease in
filtration fraction (from 17.6 +/- 1.0 to 12.6 +/- 0.4%; p less than
0.001), while the glomerular filtration rate was unchanged, thus suggesting
a prevailing efferent vasodilation. Sodium excretion rate (p less than
0.02) and fractional sodium excretion (p less than 0.025) increased
slightly but significantly in subjects with one hypertensive parent, but
not in normotensive subjects with no family history of hypertension.
Lithium clearance also rose (from 29.0 +/- 2.0 to 32.8 +/- 1.9 ml/min, p
less than 0.001), and the derived value of fractional proximal reabsorption
diminished (from 75.8 +/- 1.0 to 71.3 +/- 1.2%, p less than 0.001).
Estimated distal delivery of sodium and absolute distal sodium reabsorption
both increased significantly (p less than 0.005), while fractional distal
sodium reabsorption was unchanged.(ABSTRACT TRUNCATED AT 250 WORDS)
ARTICLES
Abnormal renal responses to calcium entry blockade in normotensive offspring of hypertensive parents
Istituto di Semeiotica Medica, Universita degli Studi di Parma, Italy.
This article has been cited by other articles:
![]() |
A. Montanari, N. Carra, P. Perinotto, V. Iori, E. Fasoli, A. Biggi, and A. Novarini Renal Hemodynamic Control by Endothelin and Nitric Oxide Under Angiotensin II Blockade in Man Hypertension, February 1, 2002; 39(2): 715 - 720. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. PERINOTTO, A. BIGGI, N. CARRA, A. ORRICO, G. VALMADRE, P. DALL'AGLIO, A. NOVARINI, and A. MONTANARI Angiotensin II and Prostaglandin Interactions on Systemic and Renal Effects of L-NAME in Humans J. Am. Soc. Nephrol., August 1, 2001; 12(8): 1706 - 1712. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Montanari, E. Tateo, E. Fasoli, D. Giberti, P. Perinotto, A. Novarini, and P. Dall'Aglio Angiotensin II Blockade Does Not Prevent Renal Effects of L-NAME in Sodium-Repleted Humans Hypertension, September 1, 1997; 30(3): 557 - 562. [Abstract] [Full Text] |
||||
![]() |
M. Epstein Calcium Antagonists and Renal Protection: Current Status and Future Perspectives Arch Intern Med, August 1, 1992; 152(8): 1573 - 1584. [Abstract] [PDF] |
||||
|
Hypertension Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1988 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |